Press Releases

Press Release

Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants issued on June 4, 2020

September 10, 2021

Press Release

Cardiol Therapeutics Appoints Michael J. Willner to its Board of Directors

September 07, 2021

Press Release

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx™ for Acute Myocarditis

August 24, 2021

Press Release

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”

August 09, 2021

Press Release

Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman

July 07, 2021

Press Release

Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting

June 30, 2021

Press Release

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT

June 28, 2021

Press Release

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

May 12, 2021

Press Release

Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering

May 06, 2021